Contingency Management for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people quit smoking. It uses a text-based program to encourage adherence to quitting methods, such as calling a support hotline and using the medication varenicline, which is known to aid smoking cessation. Researchers aim to determine if this approach helps people stay engaged with their quitting plan. The trial seeks Kansas residents who have smoked at least one cigarette a day in the past month, have a mobile phone capable of receiving texts, and can safely use varenicline. As an unphased trial, this study offers a unique opportunity to contribute to innovative smoking cessation strategies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot be on smoking cessation medication within 2 weeks before starting the trial.
What prior data suggests that this text-based contingency management intervention is safe for smoking cessation?
Research has shown that using rewards to encourage healthy habits, known as contingency management, is generally safe and effective. Studies have found it helps people quit smoking and other habits. For example, when people receive financial rewards for quitting smoking, about 10 out of 100 successfully quit for six months or more. No evidence of serious side effects from this method exists. It has been used safely in various situations, such as weight loss and substance abuse treatment, indicating it is well-tolerated. Therefore, using rewards to help people stop smoking appears safe for most individuals.12345
Why are researchers excited about this trial?
Researchers are excited about the Contingency Management approach for smoking cessation because it offers a fresh take on quitting strategies. Unlike traditional methods such as nicotine replacement therapies or behavioral counseling alone, this treatment combines mobile technology with incentives to boost counseling attendance and medication adherence. By rewarding healthy behaviors through a digital platform, it aims to enhance motivation and engagement, potentially leading to higher success rates in quitting smoking.
What evidence suggests that this text-based contingency management intervention is effective for smoking cessation?
Research has shown that contingency management (CM), which uses rewards to help people quit smoking, can significantly reduce smoking. One study found that financial incentives encouraged people to stop smoking by rewarding them for staying smoke-free. Another study demonstrated that CM effectively helps various groups, including veterans, quit smoking. This trial will evaluate the effectiveness of a mobile CM program, specifically the MedCM plus CounsCM approach, which combines mobile contingency management for counseling attendance and medication intake. Using mobile health tools for CM is also considered a cost-effective way to support quitting. Overall, CM programs have proven effective in helping people stop smoking by offering real rewards for their efforts.24678
Are You a Good Fit for This Trial?
This trial is for Kansas residents who smoke at least one cigarette daily, can speak and read English, have a mobile phone that receives texts, are insured for varenicline (a smoking cessation medication), and don't have acute renal impairment or life-threatening illnesses. Participants must have smoked in the past 30 days.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a text-based contingency management intervention to increase engagement in quitline calls and varenicline utilization
Follow-up
Participants are monitored for engagement in quitline calls and varenicline utilization
What Are the Treatments Tested in This Trial?
Interventions
- CounCM+MedCM (Health Rewards)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
University of Oklahoma
Collaborator